The president’s directive, which he said is designed to give beneficiaries more choices in their health care, could lead to higher costs for seniors. Final rules are to be written by the Department of Health and Human Services.
The program, which will roll out next year in three parts of the country, seeks to encourage workers on the company’s health plan to choose doctors that have been identified as providing “appropriate, effective and cost-efficient care.”
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.